Neuropeptide Y increases 4-aminopyridine-sensitive transient outward potassium current in rat ventricular myocytes

British Journal of Pharmacology

Volumn 135, Issue 7, 2002, Pages 1701-1706

  Heredia, M P ^a   Fernandez Velasco M ^a   Benito, G ^a   Delgado, C ^a  

^a SCHOOL OF MEDICINE   (Spain)

Author keywords

Current; Heart; Neuropeptide Y; Potassium; Protein kinase C; Transient outward

Indexed keywords

4 AMINOPYRIDINE; CALPHOSTIN C; N [2 [1,2 DIHYDRO 3,5(4H) DIOXO 1,2 DIPHENYL 1,2,4 TRIAZOL 4 YL]ETHYL] N2 [[1 [2 [4 [5,11 DIHYDRO 6(6H) OXODIBENZ[B,E]AZEPIN 11 YL] 1 PIPERAZINYL] 2 OXOETHYL]CYCLOPENTYL]ACETYL]ARGININAMIDE; NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR; PERTUSSIS TOXIN; POTASSIUM;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; DRUG BINDING; DRUG EXPOSURE; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; HEART MUSCLE CELL; HEART VENTRICLE; MALE; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; TECHNIQUE; VOLTAGE CLAMP;

4-AMINOPYRIDINE; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ELECTROPHYSIOLOGY; GTP-BINDING PROTEINS; HEART; HEART VENTRICLES; MALE; MYOCARDIUM; NEUROPEPTIDE Y; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; RATS; RATS, WISTAR; RECEPTORS, NEUROPEPTIDE Y; SIGNAL TRANSDUCTION;

EID: 0036965996     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0704643     Document Type: Article

References (36)

1. + currents in isolated adult rat ventricular myocytes. J. Gen. Physiol., 97, 973-1011.
2. BABENKO, A. & VASSORT, G. (1997). Purinergic facilitation of ATPsensitive potassium current in rat ventricular myocytes. Br. J. Pharmacol., 120, 631-638.
3. BALASUBRAMANIAM, A., SHERIFF, S., RIGEL, D.F. & FISCHER, J.E. (1990). Characterization of neuropeptide Y binding sites in rat cardiac ventricular membranes. Peptides, 11, 545-550.
4. BARRY, D.M. & NERBONNE, J.M. (1996). Myocardial potassium channels: electrophysiological and molecular diversity. Ann. Rev. Physiol., 58, 363-394.
5. BELL, D., MILLAR, C. & MCDERMOTT, B.J. (1997). Use of D-myo inositol 1,2,6 triphosphate to inhibit contractile activity in rat ventricular cardiomyocytes induced by neuropeptide Y and other cardioactive peptides through phospholipase C. Br. J. Pharmacol., 122, 1655-1660.
6. BENITAH, J.P., GOMEZ, A.M., BAILLY, P., PoNTE, D.A., BERSON, G., DELGADO, C. & LORENTE, P. (1993). Heterogeneity of the early outward current in ventricular cells isolated from normal and hypertrophied rat hearts. J. Physiol., 469, 111-138.
7. DOODS, H.N., GAIDA, W., WIELAND, H.A., DOLLINGER, H., SCHNORRENBERG, G., ESSER, F., ENGEL, W., EBERLEIN, W. & RUDOLF, K. (1999). BILE0246: a selective and high affinity neuropeptide Y Y(2) receptor antagonist. Eur. J. Pharmacol., 384, R3-R5.
8. DOODS, H.N., WIELAND, H.A., ENGEL, W., EBERLEIN, W., WILLIAM, K.D., ENTZEROTH, M., WIENEN, W. & RUDOLF, K. (1996). BIBP 3226, the first selective neuropeptide Y1 receptor antagonist: a review of its pharmacological properties. Regul. Pept., 65, 71-77.
9. DUMONT, Y., CADIEUX, A., DOODS, H., PHENG, L.H., ABOUNADER, R., HAMEL E., JACQUES, D., REGOLI, D. & QUIRION, R. (2000). BILE0246, a potent and highly selective non-peptide neuropeptide Y Y(2) receptor antagonist. Br. J. Pharamcol., 129, 1075-1088.
10. DUMONT, Y., MARTEL, J.C., FOURNIER, A. ST-PIERRE. S. & QUIRION. R. (1992). Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues. Prog. Neurobiol., 38, 125-167.
11. EDVINSSON, L., HAKANSON, R., WAHLESTEDT, C. & UDDMAN, R. (1987). Effects of neuropeptide Y on the cardiovascular system. TIPS, 8, 231-235.
12. FRANCO-CERECEDA, A., BENGTSSON, L. & LUNDBERG. J.M. (1987). Inotropic effects of calcitonin gene-related peptide, vasoactive intestinal polypeptide and seomatostatin on the human right atrium in vitro. Eur. J. Pharmacol., 134, 69-76.
13. + channel (Akvl.1a) by the activators of protein kinase C. Zool. Sci., 12, 35-44.
14. GOLDBERG, Y., TAIMOR, G., PIPER, H.M. & SCHLUTER, K.D. (1998). Intracellular signaling leads to the hypertrophic effect of neuropeptide Y. Am. J. Physiol., 275, H1207-H1215.
15. HAN, W., BARR, S.C., PACIORETTY, L.M. & GILMOUR, R.F. (1997). Restoration of the transient outward potassium current by noradrenaline in chagasic canine epicardium. J. Physiol., 500, 75-83.
16. HIRAOKA, M. & KAWANO, S. (1989). Calcium-sensitive and insensitive transient outward current in rabbit ventricular myocytes. J. Physiol., 410, 187-212.
17. HUME, J.R. & UEHARA. A. (1985). Ionic basis of the different action potential configurations of single guinea-pig atrial and ventricular myocytes. J. Physiol., 368, 525-544.
18. KOBAYASHI, E., NAKANO, H., MORIMOTO, M. & TAMAOKI, T. (1989). Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun., 159, 548-553.
19. LEE, J.E., BOKOCH, G. & LiANG, B.T. (2001). A novel cardioprotective role of RhoA: new signaling mechanism for adenosine. FASEB J., 15, 1886-1894.
20. + current by protein kinase C and protein kinase A. Circ. Res., 83, 995-1002.
21. MCDERMOTT, B.J., MILLAR, B.C., DOLAN, F.M., BELL, D. & BALASUBRAMANIAM. A. (1997). Evidence for Y1 and Y2 subtypes of neuropeptide Y receptors linked to opposing postjunctional effects observed in rat cardiac myocytes. Eur. J. Pharmacol., 336, 257-265.
22. MCDERMOTT, B.J., MILLAR, B.C. & PIPER, H.M. (1993). Cardiovascular effects of neuropeptide Y: receptor interactions and cellular mechanisms. Cardiovasc. Res., 27, 893-905.
23. MICHEL, M.C. (1991). Receptors for neuropeptide Y: multiple subtypes and multiple second messengers. Trends Pharmacol. Sci., 12, 389-394.
24. MICHEL, M.C., BECK-SICKINGER, A., COX. H., DOODS, H.N., HERZOG, H., LARHAMMAR, D., QUIRION, R., SCHWARTZ. T. & WESTFALL, T. (1998). XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol. Rev., 50, 143-150.
25. MICHEL, M.C., WIRTH, S.C., ZERKOWSKI, H.R., MAISEL, A.S. & MOTULSKY, H.J. (1989). Lack of inotropic effects of neuropeptide Y in human myocardium. J. Cardiovasc. Pharmacol., 14, 919-922.
26. MILLAR, B.C., WEIS, T., PIPER, H.M., WEBER, M., BORCHARD, U., MCDERMOTT, B.J. & BALASUBRAMANIAM. A. (1991). Positive and negative contractile effects of neuropeptide Y on ventricular cardiomyocytes. Am. J. Physiol., 261, H1727-H1733.
27. + current, by PKC. Am. J. Physiol., 273, H1775-H1786.
28. + channel diversity in the mammalian myocardium. J. Physiol., 525, 285-298.
29. to) in normal and diseased myocardium. J. Mol. Cell. Cardiol., 33, 851-872.
30. RHIM, H., KINNEY, G.A., EMMERSON. P.J. & MILLER, R.J. (1997). Regulation of neurotransmission in the arcuate nucleus of the rat by different neuropeptide Y receptors. J. Neurosci., 17, 2980-2989.
31. RUDOLF, K., EBERLEIN, W., ENGEL W., WIELAND, H.A., WILLIAM, K.D., ENTZEROTH, M., WIENEN, W., BECK-SICKINGER. A.G. & DOODS, H.N. (1994). The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226. Eur. J. Pharmacol., 271, R11-R13.
32. TSENG, G.N. & HOFFMAN, B.F. (1989). Two components of transient outward current in canine ventricular myocytes. Circ. Res., 64, 633-647.
33. WAHLESTEDT, C. & REIS, D.J. (1993). Neuropeptide Y-related peptides and their receptors are the receptors potential therapeutic drug targets? Ann. Rev. Pharmacol. Toxicol., 33, 309-352.
34. WETTWER, E., AMOS, G., POSIVAL, H. & RAVENS, U. (1994). Transient outward current in human ventricular myocytes of subepicardial and subendocardial origin. Circ. Res., 75, 473-482.
35. WICKMAN, K.D., INIGUEZ-LLUHL, J.A., DAVENPORT, P.A., TAUSSIC, R., KRAPIVINSKY, G.B., LINDER, M.E., GILMAN, A.G. & CLAPHAM, D.E. (1994). Recombinant G-protein beta gamma-subunits activate the muscarinic-gated atrial potassium channel. Nature, 368, 255-257.
36. + channels in C cells of amphibian sympathetic ganglia. Neurosci. Lett., 117, 123-128.